Collection of biological samples to study Noonan syndrome
Official title: Constitution of a Biological Collection to Study the Pathophysiology in Noonan Syndrome and to Identify Predictive Factors of Disease Progression
Run by University Hospital, Toulouse · NCT05202210 · Data updated 2026-11-12
This study is collecting blood and urine samples from people with Noonan syndrome to help researchers learn more about the condition and how it affects patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 99 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 1 site (Toulouse) |
| Status | Recruiting |
| Started | January 26, 2022 |
| Main results expected | January 26, 2027 |
| Study ends | January 26, 2032 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT05202210 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged at least 3 years or adults diagnosed with Noonan syndrome who can provide informed consent.
✕Probably not a fit
Patients who are subject to legal protection measures or are pregnant or breastfeeding may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to establish a biological collection of samples from patients with Noonan syndrome to facilitate research into the condition's pathophysiology. Patients will provide blood and urine samples during regular check-ups at the Toulouse University Hospital, with their consent. The collected samples will be used to better understand the multisystemic disorders associated with Noonan syndrome and to identify biological factors that may predict disease severity and progression.
Why it matters
Potential benefit: If successful, this study could enhance understanding of Noonan syndrome and lead to improved management and treatment options for patients.
How similar studies have gone: While this approach is focused on biological sample collection, similar studies have shown success in advancing understanding of genetic disorders through biological research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children aged at least 3 years old or adult with Noonan syndrome * Patients affiliated to or beneficiaries of a social security scheme * Patients able to receive information on the progress of the study and understand the information form to participate in the study. That implies to master the French language and not to be subject to a restriction of rights by the judicial authorities * Patients or legal representative who have given their consent to participate in the study (expression of no objection) Exclusion Criteria: * Patients subject to a legal protection measure (guardianship, curators, or safeguard of justice) * Pregnant or breastfeeding women
Where it's running
-
Purpan University Hospital
Toulouse, France Recruiting
Study contacts
- Principal investigator: Thomas EDOUARD, MD PhD — University Hospital, Toulouse
- Study coordinator: Thomas EDOUARD, MD, PhD
- Email: edouard.t@chu-toulouse.fr
- Phone: 5 34 55 85 55
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
National Registry for Noonan Syndrome (Italy)
This registry will collect genetic and clinical information from people with Noonan syndrome in Italy to understand how the condition changes over time and how treatments like growth hormone may work.
-
Neuroradiology Features in Noonan Syndrome and Gene-Linked Brain Differences
This study tests brain MRI and MR angiography in people with Noonan syndrome to see how brain imaging patterns relate to their specific genetic mutations.
-
Lipid and glucose patterns in Noonan syndrome and related RASopathies by age, sex, and genotype
This project will see how lipid and glucose levels differ by age, sex, and genetic type in people with Noonan syndrome and related RASopathies.
-
Using advanced heart MRI to improve diagnosis and risk prediction for rare cardiomyopathies
This project tests whether advanced cardiac MRI techniques can help diagnose and predict future risk for people with rare heart muscle diseases like Danon, Fabry, cardiac amyloidosis, Noonan syndrome, and cardiac sarcoidosis.
-
Using MEK inhibitors to treat hypertrophic cardiomyopathy in children with RASopathies
This study is testing if a new medication called trametinib can help children with RASopathies and hypertrophic cardiomyopathy feel better compared to standard treatment alone.
-
Therapy to help caregivers of children with genetic disorders manage stress
This study tests whether a remote therapy program can help caregivers of children with genetic disorders manage their stress better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.